Differences

This shows you the differences between two versions of the page.

--- resources:ohdsi_symposium_2017_poster_submissions [2017/09/01 01:20] – aostropolets
+++ resources:ohdsi_symposium_2017_poster_submissions [2017/11/22 19:02] (current) – maura_beaton
@@ Line 92: / Line 92: @@
   * Pratt, Nicole {{:symposium_2017:ohdsi_symposium_abstract_feasibility.pdf|The feasibility of utilising the OHDSI network to generate large-scale evidence of the safety of biologics}}
   * Pratt, Nicole {{:symposium_2017:ohdsi_symposium_abstract_biologicsstudy.pdf|Utilising the power of the OHDSI network to generate large scale evidence of the safety of biologics}}
-  * Ddymshyts, Dmitry {{:symposium_2017:abstractdymshytssymposium2017.pdf|Variability of Drug Attributes in the US Market (RxNorm) compared to selection of Worldwide Market (RxNorm Extension)}}
+  * Dymshyts, Dmitry {{:symposium_2017:abstractdymshytssymposium2017.pdf|Variability of Drug Attributes in the US Market (RxNorm) compared to selection of Worldwide Market (RxNorm Extension)}}
+  * Klebanov, Gregory {{:resources:arachne_abstract_symposium_2017_-_1.pdf|ARACHNE – Distributed OHDSI Research Network and Study Workflow Orchestration}}
+  * Busby, Ben {{:resources:ohdsi_pubrunner_abstract.pdf|PubRunner: A framework to update biomedical text mining analysis with the latest publications}}
+  * Jiang, Guoqian {{:resources:poster-fhirontopohdsi-v1.0.pdf|FHIROntopOHDSI: A Semantic Web-based Data Access Framework with the OHDSI Data Repositories Using FHIR}}
+  * Galaznik, Aaron {{:symposium_2017:abstractgalazniksymposium2017_v2.docx|}}: Predictive Modeling as an OHDSI Network Study: Treatment Non-Response in NSCLC patients treated with ALK Inhibitors
+  * Yuan,Chi {{:resources:ohdsi_poster_time_generalizability_yuan_5sept2016.pdf|Generalizability of randomized trial follow-up time to real-world practice}}
+  * Ames, Michael {{:resources:ohdsi_submission_-_ucdenver_and_google.docx|Google BigQuery and the OHDSI Ecosystem}}
+  * Kumar, Praveen {{:symposium_2017:kumar_nestsiarovich_hurwitz_lambert.pdf|Visit level suicidality/self-harm phenotyping in bipolar disorder}}
+  *Lauve, Nicolas {{:symposium_2017:lauve_nelson_young_obenchain_lambert.pdf|Local Control for patient level prediction and heterogeneity of treatment effect}}
+  * Nestsiarovich, Anastasiya {{:symposium_2017:nestsiarovich_hurwitz_mazurie_nelson_cristanti_tohen_perkins_lambert.pdf|Comparison of 30 bipolar disorder monotherapies for risk of psychiatric hospitalization}}
+***SUBMISSIONS CLOSED***